{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:03:06Z","timestamp":1785495786063,"version":"3.56.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The gut microbiome has been increasingly recognized for its potential role in schizophrenia through gut-brain interactions involving immune, neural, and metabolic pathways. This pilot study evaluated the impact of fecal microbiota transplantation (FMT) on the abundance and variability of selected fungal and archaeal species in the gut microbiota in the rat model of schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Sprague-Dawley rats using as a prenatal methylazoxymethanol acetate (MAM-E17) model of schizophrenia underwent FMT or placebo. Fecal DNA was extracted and analyzed via quantitative Real-Time PCR (qPCR) to quantify selected fungi\n                      <jats:italic>(Candida tropicalis<\/jats:italic>\n                      ,\n                      <jats:italic>Malassezia<\/jats:italic>\n                      spp.,\n                      <jats:italic>Cryptococcus neoformans<\/jats:italic>\n                      ) and archaea (\n                      <jats:italic>Methanobrevibacter smithii<\/jats:italic>\n                      ,\n                      <jats:italic>Methanosphaera stadtmanae<\/jats:italic>\n                      ) before and after intervention\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A slightly higher prevalence of\n                      <jats:italic>C. tropicalis<\/jats:italic>\n                      was noted in MAM-exposed rats compared to healthy controls (19% vs. 10%). Post-FMT,\n                      <jats:italic>C. tropicalis<\/jats:italic>\n                      colonization increased to nearly 100% across all groups, irrespective of transplantation source, indicating natural microbiome maturation rather than FMT effect.\n                      <jats:italic>Malassezia<\/jats:italic>\n                      spp. were commonly present before treatment, with their abundance significantly declining after both FMT and placebo administration, suggesting procedural impacts rather than specific FMT effects.\n                      <jats:italic>C. neoformans<\/jats:italic>\n                      and methanogenic archaea were absent.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, the results suggest that FMT has limited impact on gut fungal populations, possibly due to the developmental stage of microbiome maturation or procedural interventions. The absence of archaea underscores the complexity of the microbiome\u2019s role in neurodevelopmental disorders, highlighting the necessity for continued research into microbial influences on schizophrenia pathophysiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s43440-025-00793-8","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:54:37Z","timestamp":1761116077000},"page":"1546-1556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of fecal microbiota transplantation on the abundance and diversity of selected fungal and archaeal species in the gut microbiota in the rat model of schizophrenia"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9719-9663","authenticated-orcid":false,"given":"Agnieszka","family":"Krawczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4254-2804","authenticated-orcid":false,"given":"Tomasz","family":"Kasperski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4725-5943","authenticated-orcid":false,"given":"Tomasz","family":"Gosiewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2424-8348","authenticated-orcid":false,"given":"Agnieszka","family":"Nikiforuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6444-5637","authenticated-orcid":false,"given":"Agnieszka","family":"Potasiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-2555","authenticated-orcid":false,"given":"Zbigniew","family":"Arent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-5520","authenticated-orcid":false,"given":"Dominika","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"10039","key":"793_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","volume":"388","author":"MJ Owen","year":"2016","unstructured":"Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388(10039):86\u201397.","journal-title":"Lancet"},{"issue":"1","key":"793_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-021-03496-5","volume":"21","author":"G Li","year":"2021","unstructured":"Li G, Dai J, Liu H, Lin Y, Liu Q, Zheng K, et al. Association study between genetic variants and the risk of schizophrenia in the Chinese population based on GWAS-implicated 6p21.3-23.1 human genome region: a case-control study. BMC Psychiatry. 2021;21(1):1\u20139.","journal-title":"BMC Psychiatry"},{"key":"793_CR3","doi-asserted-by":"publisher","first-page":"110393","DOI":"10.1016\/j.pnpbp.2021.110393","volume":"111","author":"K Wang","year":"2021","unstructured":"Wang K, Xu C, Smith A, Xiao D, Navia RO, Lu Y, et al. Genome-wide association study identified INSC gene associated with Trail Making Test Part A and Alzheimer\u2019s disease related cognitive phenotypes. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110393.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"793_CR4","doi-asserted-by":"crossref","unstructured":"Wahbeh MH, Avramopoulos D. Gene-environment interactions in schizophrenia: a literature review. Genes. 12(12):1850.","DOI":"10.3390\/genes12121850"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpsychires.2021.12.033","volume":"146","author":"R Vila-Badia","year":"2022","unstructured":"Vila-Badia R, Del Cacho N, Butjosa A, Serra Arum\u00ed C, Esteban Santjusto M, Abella M, et al. Prevalence and types of childhood trauma in first episode psychosis patients. Relation with clinical onset variables. J Psychiatr Res. 2022 Feb 1;146:102\u201308.","journal-title":"J Psychiatr Res"},{"issue":"249","key":"793_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.schres.2020.02.001","volume":"1","author":"M Reddy-Thootkur","year":"2022","unstructured":"Reddy-Thootkur M, Kraguljac NV, Lahti AC. The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - a systematic review of magnetic resonance spectroscopy studies. Schizophr Res. 2022 Nov;1(249):74\u201384.","journal-title":"Schizophr Res"},{"key":"793_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/applmicrobiol5030070","volume":"5","author":"A Mardon","year":"2025","unstructured":"Mardon A, Chaudhry H, Harline J, Mardon C, Banks J, Hodgson E, et al. The gut-brain axis in schizophrenia: a systems-level understanding of psychiatric illness. Appl Microbiol. 2025;5:70.","journal-title":"Appl Microbiol"},{"issue":"1","key":"793_CR8","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1192\/j.eurpsy.2024.1765","volume":"67","author":"L Gonz\u00e1lez-Blanco","year":"2024","unstructured":"Gonz\u00e1lez-Blanco L, Dal Santo F, Garc\u00eda-Portilla MP, Alfonso M, Hern\u00e1ndez C, S\u00e1nchez-Autet M, et al. Intestinal permeability biomarkers in patients with schizophrenia: additional support for the impact of lifestyle habits. Eur Psychiatry. 2024 Dec 16;67(1):e84.","journal-title":"Eur Psychiatry"},{"key":"793_CR9","unstructured":"Tryptophan and its metabolite serotonin impact metabolic and mental disorders via the Brain-Gut-Microbiome Axis. Cells. 2025."},{"issue":"6","key":"793_CR10","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00406-022-01519-0","volume":"273","author":"J Sapienza","year":"2023","unstructured":"Sapienza J, Spangaro M, Guillemin GJ, Comai S, Bosia M. Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies. Eur Arch Psychiatry Clin Neurosci. 2023;273(6):1317\u201328.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"793_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.schres.2023.12.005","volume":"264","author":"J Sapienza","year":"2024","unstructured":"Sapienza J, Agostoni G, Dall\u2019acqua S, Sut S, Nasini S, Martini F, et al. The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy. Schizophr Res. 2024;264:71\u201380.","journal-title":"Schizophr Res"},{"key":"793_CR12","doi-asserted-by":"crossref","unstructured":"Sapienza J, Agostoni G, Comai S, Nasini S, Dall\u2019acqua S, Sut S, et al. Neuroinflammation and kynurenines in schizophrenia: impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise. Schizophr Res Cogn. 2024 Dec;38.","DOI":"10.1016\/j.scog.2024.100328"},{"key":"793_CR13","unstructured":"Krawczyk A, Salamon D, Gosiewski T. Role of gut microbiota in pathogenesis of selected chronic diseases. World Sci News. 2019;132\u201354."},{"issue":"6","key":"793_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3390\/microorganisms10061121","volume":"10","author":"K Tsamakis","year":"2022","unstructured":"Tsamakis K, Galinaki S, Alevyzakis E, Hortis I, Tsiptsios D, Kollintza E, et al. Gut microbiome: a brief review on its role in schizophrenia and first episode of psychosis. Microorganisms. 2022;10(6):1121.","journal-title":"Microorganisms"},{"key":"793_CR15","doi-asserted-by":"publisher","first-page":"127858","DOI":"10.1016\/j.micres.2024.127858","volume":"287","author":"S Qu","year":"2024","unstructured":"Qu S, Yu Z, Zhou Y, Wang S, Jia M, Chen T, et al. Gut microbiota modulates neurotransmitter and gut-brain signaling. Microbiol Res. 2024 Oct 1;287:127858.","journal-title":"Microbiol Res"},{"issue":"1","key":"793_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41537-024-00497-7","volume":"10","author":"K Zhou","year":"2024","unstructured":"Zhou K, Baranova A, Cao H, Sun J, Zhang F. Gut microbiome and schizophrenia: insights from two-sample Mendelian randomization. Schizophrenia. 2024;10(1):1\u20136.","journal-title":"Schizophrenia"},{"key":"793_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbi.2021.09.014","volume":"99","author":"Y Xu","year":"2022","unstructured":"Xu Y, Shao M, Fang X, Tang W, Zhou C, Hu X, et al. Antipsychotic-induced gastrointestinal hypomotility and the alteration in gut microbiota in patients with schizophrenia. Brain Behav Immun. 2022;99:119\u201329.","journal-title":"Brain Behav Immun"},{"key":"793_CR18","doi-asserted-by":"crossref","unstructured":"Zheng J, Lin Z, Ko CY, Xu JH, Lin Y, Wang J. Analysis of gut microbiota in patients with exacerbated symptoms of schizophrenia following therapy with amisulpride: a pilot study. Behavioural Neurol. 2022;2022.","DOI":"10.1155\/2022\/4262094"},{"key":"793_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.schres.2019.12.014","volume":"234","author":"N Vindegaard","year":"2021","unstructured":"Vindegaard N, Speyer H, Nordentoft M, Rasmussen S, Benros ME. Gut microbial changes of patients with psychotic and affective disorders: a systematic review. Schizophr Res. 2021;234:41\u201350.","journal-title":"Schizophr Res"},{"key":"793_CR20","doi-asserted-by":"crossref","unstructured":"Li S, Zhuo M, Huang X, Huang Y, Zhou J, Xiong D, et al. Altered gut microbiota associated with symptom severity in schizophrenia. PeerJ. 2020;8.","DOI":"10.7717\/peerj.9574"},{"issue":"14","key":"793_CR21","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.3390\/ijms22147671","volume":"22","author":"N Munawar","year":"2021","unstructured":"Munawar N, Ahsan K, Muhammad K, Ahmad A, Anwar MA, Shah I, et al. Hidden role of gut microbiome dysbiosis in schizophrenia: antipsychotics or psychobiotics as therapeutics? Int J Mol Sci. 2021;22(14):7671.","journal-title":"Int J Mol Sci"},{"key":"793_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jpsychires.2024.01.036","volume":"171","author":"B Misiak","year":"2024","unstructured":"Misiak B, Pawlak E, Rembacz K, Kotas M, \u017bebrowska-R\u00f3\u017ca\u0144ska P, Kujawa D, et al. Associations of gut microbiota alterations with clinical, metabolic, and immune-inflammatory characteristics of chronic schizophrenia. J Psychiatr Res. 2024 Mar;171:152\u201360.","journal-title":"J Psychiatr Res"},{"key":"793_CR23","doi-asserted-by":"crossref","unstructured":"Fumagalli A, Castells-Nobau A, Trivedi D, Garre-Olmo J, Puig J, Ramos R, et al. Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism. Gut Microbes. 2025;17(1).","DOI":"10.1080\/19490976.2025.2455506"},{"key":"793_CR24","doi-asserted-by":"crossref","unstructured":"Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, et al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv. 2019 Feb;5(2).","DOI":"10.1126\/sciadv.aau8317"},{"key":"793_CR25","unstructured":"Lodge DJ. The MAM rodent model of schizophrenia. Curr Protoc Neurosci. 2013, Chapter, 9: Unit 9.43."},{"key":"793_CR26","doi-asserted-by":"crossref","unstructured":"Gheorghe CE, Ritz NL, Martin JA, Wardill HR, Cryan JF, Clarke G. Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls. Gut Microbes. 2021;13(1).","DOI":"10.1080\/19490976.2021.1941711"},{"key":"793_CR27","doi-asserted-by":"crossref","unstructured":"Bokoliya SC, Dorsett Y, Panier H, Zhou Y. Procedures for fecal microbiota transplantation in murine microbiome studies. Front Cell Infect Microbiol. 2021;21(11).","DOI":"10.3389\/fcimb.2021.711055"},{"key":"793_CR28","doi-asserted-by":"crossref","unstructured":"Krawczyk A, Salamon D, Kowalska-Duplaga K, Bogiel T, Gosiewski T. Association of fungi and Archaea of the gut microbiota with Crohn\u2019s disease in pediatric patients-pilot study. Pathogens. 2021;10(9).","DOI":"10.3390\/pathogens10091119"},{"issue":"3","key":"793_CR29","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1128\/AEM.69.3.1775-1782.2003","volume":"69","author":"NE Brinkman","year":"2003","unstructured":"Brinkman NE, Haugland RA, Wymer LJ, Byappanahalli M, Whitman RL, Vesper SJ. Evaluation of a rapid, quantitative real-time PCR method for enumeration of pathogenic candida cells in water. Appl Environ Microbiol. 2003 Mar;69(3):1775\u201382.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"793_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2009.05.005","volume":"65","author":"V Veron","year":"2009","unstructured":"Veron V, Simon S, Blanchet D, Aznar C. Real-time polymerase chain reaction detection of Cryptococcus neoformans and Cryptococcus gattii in human samples. Diagn Microbiol Infect Dis. 2009 Sep;65(1):69\u201372.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"793_CR31","first-page":"1","volume":"2014","author":"Z Xie","year":"2014","unstructured":"Xie Z, Ran Y, Zhang H, Zhang M, Wan H, Li C. An analysis of the malassezia species distribution in the skin of patients with Pityriasis Versicolor in Chengdu, China. Sci World J. 2014;2014:1\u20136.","journal-title":"Sci World J"},{"issue":"9","key":"793_CR32","doi-asserted-by":"publisher","first-page":"e 7063","DOI":"10.1371\/journal.pone.0007063","volume":"4","author":"B Dridi","year":"2009","unstructured":"Dridi B, Henry M, El Kh\u00e9chine A, Raoult D, Drancourt M. High prevalence of methanobrevibacter smithii and methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One. 2009;4(9):e 7063.","journal-title":"PLoS One"},{"issue":"1","key":"793_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npjschz.2016.18","volume":"2","author":"EG Severance","year":"2016","unstructured":"Severance EG, Gressitt KL, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CL, et al. Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder. NPJ Schizophr. 2016;2(1):1\u20137.","journal-title":"NPJ Schizophr"},{"issue":"2","key":"793_CR34","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3233\/JAD-141386","volume":"43","author":"D Pisa","year":"2015","unstructured":"Pisa D, Alonso R, Juarranz A, R\u00e1bano A, Carrasco L. Direct visualization of fungal infection in brains from patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2015;43(2):613\u201324.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"793_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/JLB.2MA0820-259R","volume":"109","author":"AJ Wolf","year":"2021","unstructured":"Wolf AJ, Limon JJ, Nguyen C, Prince A, Castro A, Underhill DM. Malassezia spp. induce inflammatory cytokines and activate NLRP3 inflammasomes in phagocytes. J Leukoc Biol. 2021;109(1):161\u201372.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"793_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.chom.2019.01.007","volume":"25","author":"JJ Limon","year":"2019","unstructured":"Limon JJ, Tang J, Li D, Wolf AJ, Michelsen KS, Funari V, et al. Malassezia is associated with Crohn\u2019s disease and exacerbates colitis in mouse models. Cell Host Microbe. 2019 Mar 13;25(3):377\u201388.e6.","journal-title":"Cell Host Microbe"},{"key":"793_CR37","doi-asserted-by":"publisher","first-page":"115149","DOI":"10.1016\/j.bbr.2024.115149","volume":"472","author":"X Yuan","year":"2024","unstructured":"Yuan X, Li X, Hei G, Zhang X, Song X. Intestinal mycobiota dysbiosis associated inflammation activation in chronic schizophrenia. Behavioural Brain Res. 2024 Aug;472:115149.","journal-title":"Behavioural Brain Res"},{"issue":"6","key":"793_CR38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/EC.00039-10","volume":"9","author":"K Voelz","year":"2010","unstructured":"Voelz K, May RC. Cryptococcal interactions with the host immune system. Eukaryot Cell. 2010 Jun;9(6):835\u201346.","journal-title":"Eukaryot Cell"},{"key":"793_CR39","doi-asserted-by":"crossref","unstructured":"Hadrich I, Turki M, Chaari I, Abdelmoula B, Gargouri R, Khemakhem N, et al. Gut mycobiome and neuropsychiatric disorders: insights and therapeutic potential. Front Cell Neurosci. 2025 Jan 8;18.","DOI":"10.3389\/fncel.2024.1495224"},{"key":"793_CR40","doi-asserted-by":"crossref","unstructured":"Raymann K, Moeller AH, Goodman AL, Ochman H. Unexplored archaeal diversity in the great ape gut microbiome. mSphere. 2017 Feb 22;2(1).","DOI":"10.1128\/mSphere.00026-17"},{"issue":"12","key":"793_CR41","doi-asserted-by":"publisher","first-page":"e0226243","DOI":"10.1371\/journal.pone.0226243","volume":"14","author":"R Mu\u00f1oz-Tamayo","year":"2019","unstructured":"Mu\u00f1oz-Tamayo R, Popova M, Tillier M, Morgavi DP, Morel JP, Fonty G, et al. Hydrogenotrophic methanogens of the mammalian gut: functionally similar, thermodynamically different-A modelling approach. PLoS One. 2019 Dec 11;14(12):e0226243.","journal-title":"PLoS One"},{"key":"793_CR42","doi-asserted-by":"crossref","unstructured":"Bang C, Weidenbach K, Gutsmann T, Heine H, Schmitz RA. The intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cells. PLoS One. 2014;9(6).","DOI":"10.1371\/journal.pone.0099411"},{"key":"793_CR43","doi-asserted-by":"crossref","unstructured":"Mohammed V, Muthuramamoorthy M, Arasu MV, Arockiaraj J. Gut microbiome and mitochondrial crosstalk in Schizophrenia, a mental disability: emerging mechanisms and therapeutic targets. Neurosci Biobehav Rev. 2025;106371.","DOI":"10.1016\/j.neubiorev.2025.106371"},{"issue":"1","key":"793_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther. 2024;9(1):1\u201353.","journal-title":"Signal Transduct Target Ther"},{"key":"793_CR45","doi-asserted-by":"crossref","unstructured":"Yuan X, Li X, Hei G, Zhang X, Song X. Intestinal mycobiota dysbiosis associated inflammation activation in chronic schizophrenia. Behav Brain Res. 2024;472.","DOI":"10.1016\/j.bbr.2024.115149"},{"key":"793_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.schres.2022.10.011","volume":"250","author":"X Yuan","year":"2022","unstructured":"Yuan X, Li X, Kang Y, Pang L, Hei G, Zhang X, et al. Gut mycobiota dysbiosis in drug-na\u00efve, first-episode schizophrenia. Schizophr Res. 2022;250:76\u201386.","journal-title":"Schizophr Res"},{"key":"793_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2016.11.019","volume":"62","author":"EG Severance","year":"2017","unstructured":"Severance EG, Gressitt KL, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CLG, et al. Probiotic normalization of Candida albicans in schizophrenia: a randomized, placebo-controlled, longitudinal pilot study. Brain Behav Immun. 2017 May 1;62:41\u201345.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"793_CR48","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41398-024-03183-5","volume":"14","author":"X Liu","year":"2024","unstructured":"Liu X, Ling Z, Cheng Y, Wu L, Shao L, Gao J, et al. Oral fungal dysbiosis and systemic immune dysfunction in Chinese patients with schizophrenia. Transl Psychiatry. 2024 Nov 21;14(1):475.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"793_CR49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12035-024-04270-w","volume":"62","author":"B Naik","year":"2025","unstructured":"Naik B, Sasikumar J, Das SP. From skin and gut to the brain: the infectious journey of the human commensal fungus malassezia and its neurological consequences. Mol Neurobiol. 2025 Jan 14;62(1):533\u201356.","journal-title":"Mol Neurobiol"},{"issue":"20","key":"793_CR50","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.3390\/nu15204391","volume":"15","author":"S Ju","year":"2023","unstructured":"Ju S, Shin Y, Han S, Kwon J, Choi TG, Kang I, et al. The gut-brain axis in schizophrenia: the implications of the gut microbiome and SCFA production. Nutrients. 2023 Oct 16;15(20):4391.","journal-title":"Nutrients"},{"key":"793_CR51","doi-asserted-by":"crossref","unstructured":"Buttar J, Kon E, Lee A, Kaur G, Lunken G. Effect of diet on the gut mycobiome and potential implications in inflammatory bowel disease. Gut Microbes. 2024 Dec 31;16(1).","DOI":"10.1080\/19490976.2024.2399360"},{"key":"793_CR52","doi-asserted-by":"crossref","unstructured":"Shankar J. Food habit associated mycobiota composition and their impact on human health. Front Nutr. 2021 Nov 22;8.","DOI":"10.3389\/fnut.2021.773577"},{"issue":"1","key":"793_CR53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40168-017-0373-4","volume":"5","author":"AK Nash","year":"2017","unstructured":"Nash AK, Auchtung TA, Wong MC, Smith DP, Gesell JR, Ross MC, et al. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome. 2017;5(1):153.","journal-title":"Microbiome"},{"issue":"6","key":"793_CR54","first-page":"624","volume":"4","author":"P Sengupta","year":"2013","unstructured":"Sengupta P. The laboratory rat: relating its age with human\u2019s. Int J Prev Med. 2013 Jun;4(6):624\u201330.","journal-title":"Int J Prev Med"},{"issue":"3","key":"793_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1176\/appi.focus.20160007","volume":"14","author":"J Kendhari","year":"2016","unstructured":"Kendhari J, Shankar R, Young-Walker L. A review of childhood-onset schizophrenia. Focus (Madison). 2016 Jul;14(3):328\u201332.","journal-title":"Focus (Madison)"},{"issue":"5","key":"793_CR56","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/ejn.15599","volume":"55","author":"ZX Phuna","year":"2022","unstructured":"Phuna ZX, Madhavan P. A closer look at the mycobiome in Alzheimer\u2019s disease: fungal species, pathogenesis and transmission. Eur J Neurosc. 2022;55(5):1291\u2013321.","journal-title":"Eur J Neurosc"},{"key":"793_CR57","doi-asserted-by":"crossref","unstructured":"Laurence M, Benito-Le\u00f3n J, Calon F. Malassezia and Parkinson\u2019s disease. Front Neurol. 2019 Jul 24;10.","DOI":"10.3389\/fneur.2019.00758"},{"issue":"1","key":"793_CR58","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.1186\/1757-1626-2-9084","volume":"2","author":"PY Prakash","year":"2009","unstructured":"Prakash PY, Sugandhi RP. Neuropsychiatric manifestation of confusional psychosis due to Cryptococcus neoformans var. grubii in an apparently immunocompetent host: a case report. Cases J. 2009 Dec 25;2(1):9084.","journal-title":"Cases J"},{"key":"793_CR59","doi-asserted-by":"crossref","unstructured":"Esher SK, Zaragoza O, Alspaugh JA. Cryptococcal pathogenic mechanisms: a dangerous trip from the environment to the brain. Mem Inst Oswaldo Cruz. 2018;113(7).","DOI":"10.1590\/0074-02760180057"},{"issue":"10","key":"793_CR60","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/jof8101069","volume":"8","author":"Y Chen","year":"2022","unstructured":"Chen Y, Shi ZW, Strickland AB, Shi M. Cryptococcus neoformans infection in the central nervous system: the battle between host and pathogen. J Fungi. 2022;8(10):1069.","journal-title":"J Fungi"},{"key":"793_CR61","first-page":"610","volume":"74","author":"A Krawczyk","year":"2020","unstructured":"Krawczyk A, Salamon D, Kowalska-Duplaga K, Gosiewski T. Gut archaea in the context of human diseases. PHMD. 2020 Dec 28;74:610\u201317.","journal-title":"PHMD"},{"key":"793_CR62","doi-asserted-by":"publisher","first-page":"102629","DOI":"10.1016\/j.anaerobe.2022.102629","volume":"77","author":"D Mafra","year":"2022","unstructured":"Mafra D, Ribeiro M, Fonseca L, Regis B, Cardozo LFMF, Fragoso dos Santos H, et al. Archaea from the gut microbiota of humans: could be linked to chronic diseases? Anaerobe. 2022 Oct 1;77:102629.","journal-title":"Anaerobe"},{"issue":"2","key":"793_CR63","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1128\/IAI.71.2.591-596.2003","volume":"71","author":"PB Eckburg","year":"2003","unstructured":"Eckburg PB, Lepp PW, Relman DA. Archaea and their potential role in human disease. Infect Immun. 2003;71(2):591.","journal-title":"Infect Immun"},{"issue":"7\u20138","key":"793_CR64","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.resmic.2008.06.007","volume":"159","author":"A Mihajlovski","year":"2008","unstructured":"Mihajlovski A, Alric M, Brug\u00e8re JF. A putative new order of methanogenic archaea inhabiting the human gut, as revealed by molecular analyses of the mcrA gene. Res Microbiol. 2008 Sep 1;159(7\u20138):516\u201321.","journal-title":"Res Microbiol"},{"issue":"4","key":"793_CR65","first-page":"575","volume":"4","author":"Y Peled","year":"1985","unstructured":"Peled Y, Gilat T, Liberman E, Bujanover Y. The development of methane production in childhood and adolescence. J Pediatr Gastroenterol Nutr. 1985;4(4):575\u201379.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"793_CR66","doi-asserted-by":"crossref","unstructured":"Krawczyk A, Gosiewski T, Zapa\u0142a B, Kowalska-Duplaga K, Salamon D. Alterations in intestinal Archaea composition in pediatric patients with Crohn\u2019s disease based on next-generation sequencing - a pilot study. Gut Microbes. 2023;15(2).","DOI":"10.1080\/19490976.2023.2276806"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00793-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:03:37Z","timestamp":1764119017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00793-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00793-8","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with EU Directive 2010\/63\/EU and subsequent regulations of the Polish Ministry of Agriculture and Rural Development and approved by the 2nd Local Institutional Animal Care and Use Committee in Krakow, issued on 21 July 2022, resolution number 213\/2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}